Addus HomeCare Co. (NASDAQ:ADUS) Receives Average Recommendation of “Moderate Buy” from Brokerages

Addus HomeCare Co. (NASDAQ:ADUS) has received a consensus recommendation of “Moderate Buy” from the seven research firms that are currently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell rating and six have assigned a buy rating to the company. The average twelve-month price objective among analysts that have issued ratings on the stock in the last year is $103.00.

A number of equities research analysts have weighed in on ADUS shares. Oppenheimer restated an “outperform” rating and issued a $118.00 target price on shares of Addus HomeCare in a research report on Tuesday, March 26th. Royal Bank of Canada reissued an “outperform” rating and issued a $102.00 price objective on shares of Addus HomeCare in a research note on Thursday, February 29th. William Blair reaffirmed an “outperform” rating on shares of Addus HomeCare in a research note on Monday, February 5th. Finally, Barclays cut shares of Addus HomeCare from an “equal weight” rating to an “underweight” rating and set a $83.00 price target on the stock. in a research report on Tuesday.

Institutional Investors Weigh In On Addus HomeCare

Hedge funds have recently modified their holdings of the stock. Exchange Traded Concepts LLC increased its stake in Addus HomeCare by 0.8% in the 4th quarter. Exchange Traded Concepts LLC now owns 14,310 shares of the company’s stock worth $1,329,000 after purchasing an additional 113 shares in the last quarter. Guinness Asset Management LTD increased its position in shares of Addus HomeCare by 2.7% in the third quarter. Guinness Asset Management LTD now owns 5,267 shares of the company’s stock worth $449,000 after acquiring an additional 137 shares in the last quarter. GAMMA Investing LLC raised its holdings in shares of Addus HomeCare by 40.8% during the first quarter. GAMMA Investing LLC now owns 556 shares of the company’s stock valued at $57,000 after acquiring an additional 161 shares during the period. Sheets Smith Wealth Management lifted its position in shares of Addus HomeCare by 2.5% in the 3rd quarter. Sheets Smith Wealth Management now owns 6,892 shares of the company’s stock valued at $587,000 after acquiring an additional 168 shares in the last quarter. Finally, Assetmark Inc. boosted its stake in Addus HomeCare by 17.1% in the 3rd quarter. Assetmark Inc. now owns 1,331 shares of the company’s stock worth $113,000 after purchasing an additional 194 shares during the period. 95.35% of the stock is owned by hedge funds and other institutional investors.

Addus HomeCare Stock Performance

ADUS stock opened at $91.70 on Friday. The company has a 50-day simple moving average of $97.73 and a 200 day simple moving average of $91.59. The company has a market capitalization of $1.49 billion, a P/E ratio of 23.88, a PEG ratio of 1.87 and a beta of 0.96. The company has a quick ratio of 1.38, a current ratio of 1.38 and a debt-to-equity ratio of 0.18. Addus HomeCare has a fifty-two week low of $77.30 and a fifty-two week high of $114.97.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings results on Monday, February 26th. The company reported $1.21 EPS for the quarter, topping analysts’ consensus estimates of $1.04 by $0.17. The company had revenue of $276.35 million for the quarter, compared to the consensus estimate of $274.02 million. Addus HomeCare had a net margin of 5.91% and a return on equity of 9.70%. Sell-side analysts predict that Addus HomeCare will post 4.38 earnings per share for the current fiscal year.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.